Management at Marine Farm has decided to suspend harvesting of salmon at all its
sites at Hoganess Salmon, on the west coast of Shetland, following the loss of
approximately 6,000 fish after a routine sea lice treatment. The reason for
doing so is suspicion of use of lice products not approved for salmon.


The following statement from the Company's wholly owned subsidiary Lakeland
Group has been released today:

Lakeland Group suspends all harvesting at sites that have been treated for sea
lice in Shetland

The Lakeland Group has announced today, August 27, that it has formally
suspended all harvesting of salmon at its Hoganess sites in Shetland, following
the loss of approximately 6,000 fish after a routine sea lice treatment.

It is still not clear what caused the mortalities in one of the pens.  The
Company will continue to work closely with the Scottish Environmental and
Protection Agency (SEPA), the animal welfare charity Scottish SPCA, the Food
Standards Agency (FSA) and local Environmental Health Officers to determine the
cause, although this may take a number of weeks while tests are undertaken.
Moreover, the Company is working closely with the authorities to reassure them
that none of the fish from this site have entered the food chain after the
incident.

Lakeland has hired a team of external experts to carry out an internal
investigation. So far, this investigation has uncovered that during the
treatment, which protects salmon from a parasite which affects wild and farmed
fish, lice products not approved for salmon may have been used. Needless to say,
the use of such products will be in conflict with the Company's systems and
public regulations.

The focus of the investigation will be to uncover all facts in the incident and
to prevent this from happening again. Clearly the possibility of improper use of
compounds has indicated a failing in the Company systems and the priority is to
address this effectively and as quickly as possible.

Lakeland considers this as a very serious matter and has not harvested fish from
the site in question since the incident. The Company will not harvest or move
fish from that site until a satisfactory outcome has been reached.


The direct financial effect of the mortalities in connection with the sea lice
treatment is assumed not to be significant. The company is taking necessary
actions to limit the indirect effects of the incident.

For further information, please contact CEO Bjørn Myrseth
Tel: +47 55 90 44 70
e-mail:bjorn.myrseth@marinefarms.no

This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)


[HUG#1441003]








This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: Marine Farms ASA via Thomson Reuters ONE